Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures : a systematic review and network meta-analysis

Simpson, E. orcid.org/0000-0001-7353-5979, Martyn-St James, M., Hamilton, J. et al. (4 more authors) (2020) Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures : a systematic review and network meta-analysis. Bone, 130. ISSN 8756-3282

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Elsevier. This is an author produced version of a paper subsequently published in Bone. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Osteoporosis; Systematic review; Network meta-analysis; Fragility fracture; Anti-resorptive agents; Bone-forming agents
Dates:
  • Accepted: 9 August 2019
  • Published (online): 15 October 2019
  • Published: 1 January 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Funding Information:
FunderGrant number
National Institute for Health Research14/25/02
Depositing User: Symplectic Sheffield
Date Deposited: 28 Aug 2019 11:51
Last Modified: 03 Dec 2019 12:49
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.bone.2019.115081

Download

Accepted Version


Embargoed until: 15 October 2020

Filename: Osteop__Nonbis_review_Author_copy.pdf

Licence: CC-BY-NC-ND 4.0

Request a copy

Share / Export

Statistics